Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

BioNTech SE (22UAy)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
81.40 +0.50    +0.62%
26/04 - Closed. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Germany
ISIN:  US09075V1026 
S/N:  A2PSR2
  • Volume: 18,438
  • Bid/Ask: 81.35 / 81.70
  • Day's Range: 80.70 - 82.65
BioNTech 81.40 +0.50 +0.62%

22UAy Recent Sentiments

 
This page contains information on users’ sentiments for the BioNTech SE stock, which are displayed both on charts of different periods of time and on a detailed table.
BearishBullish
Start Date Username Call Open Rate End Date Chg. %
Apr 18, 2024 Hans Glück   80.25 -1.43%
Apr 02, 2024 Juljan Schelling   86.65 Apr 26, 2024 @ 81.40 -6.06%
Mar 27, 2024 Benjamin Krause   85.80 Apr 19, 2024 @ 81.45 -5.07%
Mar 26, 2024 Jürgen Fröhlich   85.74 Apr 19, 2024 @ 81.45 -5.00%
Mar 19, 2024 Armin König   86.74 Apr 12, 2024 @ 81.10 -6.50%
Mar 11, 2024 Silvia Roloff   82.52 Apr 05, 2024 @ 83.20 -0.82%
Mar 05, 2024 Hans Glück   81.10 Mar 29, 2024 @ 85.50 -5.43%
Feb 21, 2024 Juljan Schelling   83.68 Mar 15, 2024 @ 85.16 +1.77%
Feb 19, 2024 Andreas Mendt   84.72 Mar 15, 2024 @ 85.16 +0.52%
Feb 16, 2024 Silvia Roloff   86.18 Mar 08, 2024 @ 83.14 +3.53%
Feb 05, 2024 Jürgen Fröhlich   87.00 Mar 01, 2024 @ 83.90 +3.56%
Jan 17, 2024 Juljan Schelling   89.48 Feb 09, 2024 @ 86.42 -3.42%
Jan 02, 2024 Markus Weber Frede   102.30 Jan 26, 2024 @ 87.56 -14.41%
Jan 02, 2024 Juljan Schelling   101.35 Jan 16, 2024 @ 94.38 -6.88%
Dec 29, 2023 Silvia Roloff   95.10 Jan 19, 2024 @ 90.24 +5.11%
Dec 12, 2023 Michi Eule   90.94 Jan 05, 2024 @ 102.00 +12.16%
Dec 08, 2023 Jürgen Fröhlich   94.16 Dec 29, 2023 @ 95.10 +1.00%
Dec 06, 2023 Markus Weber Frede   91.12 Dec 29, 2023 @ 95.10 +4.37%
Nov 30, 2023 Juljan Schelling   94.50 Dec 22, 2023 @ 95.74 +1.31%
Nov 22, 2023 Kyriakos Mavridis   89.16 Dec 15, 2023 @ 93.60 +4.98%
Nov 03, 2023 ElkeEmmyJane   87.22 Nov 30, 2023 @ 90.78 +4.08%
Nov 02, 2023 Richard Radloff   88.88 Nov 07, 2023 @ 91.56 +3.02%
Oct 25, 2023 Chaled Qyou   90.94 Nov 30, 2023 @ 90.78 +0.18%
Oct 25, 2023 Ayse Sahakalkan   90.74 Nov 30, 2023 @ 90.78 +0.04%
Sep 21, 2023 Andrea Ulrich   100.85 Nov 30, 2023 @ 90.78 -9.99%
Sep 04, 2023 luigi montinaro   114.20 Nov 30, 2023 @ 90.78 -20.51%
Aug 30, 2023 Juljan Schelling   114.65 Nov 30, 2023 @ 90.78 -20.82%
Aug 23, 2023 Juljan Schelling   114.45 Aug 30, 2023 @ 114.65 +0.17%
Aug 22, 2023 Markus Weber Frede   113.55 Nov 30, 2023 @ 90.78 -20.05%
Aug 17, 2023 Dominik Heyer   103.55 Nov 30, 2023 @ 90.78 -12.33%
Aug 16, 2023 Veit Baumgärtel   99.76 Nov 30, 2023 @ 90.78 +9.00%
Aug 07, 2023 Erom Karaman   90.74 Nov 30, 2023 @ 90.78 +0.04%
Aug 04, 2023 Raúl Ballesteros   97.98 Nov 30, 2023 @ 90.78 -7.35%
Jul 26, 2023 Emely Hu   96.72 Nov 30, 2023 @ 90.78 +6.14%
Jul 24, 2023 Hans Glück   98.00 Nov 30, 2023 @ 90.78 +7.37%
Jul 07, 2023 Jörg Heinrich   97.38 Nov 30, 2023 @ 90.78 -6.78%
Jul 04, 2023 grafik ziomal   100.00 Nov 30, 2023 @ 90.78 -9.22%
Jun 20, 2023 Jo Ca   102.15 Nov 30, 2023 @ 90.78 -11.13%
Jun 14, 2023 David Gabriel   103.15 Jul 15, 2023 @ 96.64 +6.31%
Jun 13, 2023 Ronny Butze   101.45 Nov 27, 2023 @ 90.22 -11.07%
Jun 13, 2023 Konrad Cimander   101.50 Nov 30, 2023 @ 90.78 -10.56%
Jun 05, 2023 Wilhelm Fröhle   100.60 Nov 30, 2023 @ 90.78 -9.76%
May 31, 2023 Jürgen Fröhlich   97.72 Nov 30, 2023 @ 90.78 +7.10%
May 24, 2023 Juljan Schelling   108.10 Aug 23, 2023 @ 114.10 +5.55%
May 24, 2023 Andre Leiteritz   108.55 Nov 30, 2023 @ 90.78 -16.37%
May 24, 2023 Juljan Schelling   109.45 May 24, 2023 @ 108.05 -1.28%
May 17, 2023 HeinzDieter Scholl   98.52 Nov 30, 2023 @ 90.78 -7.86%
May 09, 2023 Juljan Schelling   98.30 May 23, 2023 @ 105.55 +7.38%
May 05, 2023 Constantin Fillipp   97.52 Nov 30, 2023 @ 90.78 +6.91%
May 03, 2023 Martin Dreyling   100.00 Oct 12, 2023 @ 103.00 -3.00%
More
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

BNTX Comments

Write your thoughts about Biontech SE
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Besim Ersan
Besim Ersan Apr 11, 2024 2:44AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Any news from anti-cancer works?..
Reply
0 0
Report
Jeromy Pow
Jeromy Pow Sep 29, 2023 1:17PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
hope BNTX will bring their anti-cancer pipeline of the future forward so this will go to moon again and beyond! I especially love the fact that they are developing something against lung cancer!
Reply
5 4
Report
TheGlobe Trade
TheGlobe Trade Jun 27, 2023 3:31AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
300% Gain from here Gauranteed
Reply
5 4
Report
TheGlobe Trade
TheGlobe Trade Apr 27, 2023 9:47AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Thank you MM
Reply
1 2
Report
TheGlobe Trade
TheGlobe Trade Apr 24, 2023 7:33AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Strong Buy. This is a steal!
Reply
2 3
Report
Donavan Allen
Donavan Allen Mar 27, 2023 7:10AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
How about those earnings?! 👀
Reply
1 0
Report
Carlos GV
Carlos GV Feb 24, 2023 9:46AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
sold this trash... bye bye
Reply
3 3
Report
Jay Ow
Jay Ow Dec 07, 2022 6:53PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
who want buy this can you tell me. So many court is coming. They will must pay a lot for deaths. Full twitter so whole world know
Reply
2 15
Report
Alper Drn
Alper Drn Dec 07, 2022 6:53PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Will buy more..
Reply
8 1
Report
cc cc
cc cc Dec 07, 2022 6:53PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
They cant be sued. They had all emergency approval, meaning all goverments waived the right to sue. That was a free lunch for these companies...you have to sue the governments
Reply
1 0
Report
Ying Yu
Ying Yu Nov 10, 2022 4:58AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
The mRNA vaccine looks like a joke in the vaccine history. It couldn't stop COVID infection and spreading. Biden, Fauci, the head of CDC and The CEO of Pfizer were infected COVID virus after they got 4 shots of mRNA vaccine. Does mRNA vaccine can generate enough folded spike protein as antigen for Antigen presenting cells? Who knows? mRNA vaccine looks like generating shot term nonspecific immune response by its longer RNA chain.
Reply
2 22
Report
murat ribar
murat ribar Nov 10, 2022 4:58AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
You mean China is a big performer. Funny.
Reply
1 0
Report
Jack Black
Jack Black Sep 14, 2022 5:03PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Anyone can recommend me some books to improve my operations? In particular on how to manage my capital. Thank you
Reply
3 1
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email